Home »
CGT CDMO
Cell and Gene Therapy Services
Cell and gene therapy (CGT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. GenScript develops GMP platform to provide vectors, including viral vectors and non-viral vectors. Following the new drug development process, plasmid and virus in different quality levels are provided to meet requirements in different stages with rapid turn-around time.
Vector Manufacturing Service along with The CGT Development
-
Preclinical
IND Filing
Phase I
Phase II
Phase III
BLA/NDA
Commercial
PreCMC GradeGMPro™ GradeGMP GradePreCMC GradeGMPro™ GradeGMP GradeGMPro™ PlasmidLentiviral
Vector CMCAAV Vector
CMCmRNA CMC
